Company Overview and News

 
NZ shares fall most across Asia; Z Energy still under pressure

2018-10-19 nzherald.co.nz
New Zealand shares fell the most across Asia as Z Energy led the market lower for another day amid rising oil prices, growing competition and the threat of increased regulation.
CEN PGC AIR FCREY ZNRGF NZTCF RYM ACKDF ANZFY AUKNY AIZ COENF SKT ZNZ SYKWF CEN SKKTY AIA FBU RHCGF SPKKY NZTCY EBOSY SPK ZEL FRCEF EBO COENY KWIPF EBOSF AIA FBU ANZLY RYHTY ANZFF MEZ EBO

 
Restaurant Brands leads NZ shares lower

2018-10-09 nzherald.co.nz
New Zealand shares fell for a seventh day. Rising US bond yields kept a lid on equity markets across Asia, weighing on growth-orientated stocks such as A2 Milk Co and Pushpay Holdings.
AIR FCREY ZNRGF NZTCF RYM ACKDF ANZFY AUKNY AIZ SKT ZNZ SYKWF PPSHY SKKTY SML AIA FBU RHCGF SPKKY NZTCY SPK ZEL FRCEF AIA FBU ANZLY RYHTY ANZFF MEZ

 
Plans beyond nationwide boycott to target petrol companies one by one

2018-10-09 nzherald.co.nz
An organiser behind the nationwide boycott of petrol stations later this month says there are further plans to target each petrol company one by one if necessary.
ZNZ ZNRGF ZEL

 
Z Energy responds to Jacinda Ardern's claim customers being fleeced

2018-10-08 nzherald.co.nz
Z Energy has had no increase in its petrol margins over the past year and Prime Minister Jacinda Ardern's attack on petrol retailers' pricing is "inconsistent with Z's own experience," chief executive Mike Bennetts says.
ZNZ ZNRGF ZEL

 
'Time to take a stand': Kiwis set for nationwide petrol boycott

2018-10-04 nzherald.co.nz
Disgruntled Kiwis are set to take a stand against the petrol industry and the Government over petrol prices, with plans to boycott all petrol stations around the country.
ZNZ ZNRGF ZEL

 
NZ shares edge up, Fletcher Building leads market higher

2018-09-26 nzherald.co.nz
New Zealand shares edged higher as improved confidence lifted building and tourism stocks. Rising oil prices kept investors nervous about higher energy costs for companies, and was identified as a headwind for Air New Zealand at its annual meeting.
CEN PYIYY AIR FCREY ZNRGF ACKDF ANZFY AUKNY AIZ COENF ZNZ CEN SML AIA FBU ZEL FRCEF COENY KWIPF AIA FBU THL ANZLY ANZFF MEZ PFI

 
Marsden Point oil refinery hits near-record profit

2018-09-18 nzherald.co.nz
The Marsden Point oil refinery processed a near-record 7.62 million barrels of oil during the past two months.
ZNZ ZNRGF ZEL

 
NZ shares surge to record as market reopens

2018-08-29 nzherald.co.nz
New Zealand shares surged to a record as the market reopened after yesterday's platform failure. Synlait Milk and A2 Milk Co led the gains.
CEN FBU WBC FCREY ZNRGF WEBNF WBK FRCEF ZEL COENY COENF SKT ZNZ GNE SYKWF WBC FBU CEN SNZ SKKTY GNE GEL SML

 
NZ shares hit record; Synlait, a2 gain while Sky TV, Z Energy drop

2018-08-27 nzherald.co.nz
New Zealand shares hit a record, led higher by Synlait Milk and a2 Milk Co while Sky Network Television continued Friday's decline.
MQBKY AIA MHI ZNRGF MXRHY MCQEF ACKDF ZEL AUKNY SKT ZNZ SYKWF AIA SKKTY SKLUY SKL MQG SML MXRHF

 
Z Energy to take major stake in Flick Electric

2018-08-26 radionz.co.nz
Fuel retailer Z Energy is diversifying with a move to take a major stake in electricity retailer, Flick Electric.
ZNZ ZNRGF ZEL

 
Z Energy's $46m power play for Flick Electric

2018-08-26 nzherald.co.nz
Z Energy will pay $46 million for a 70 per cent shareholding in Flick Electric, the retail electricity supplier that was the first in the country to offer customers access to the spot price of electricity.
ZNZ ANZLY AIR ZNRGF ANZFF ANZFY ZEL AIZ

 
Māori leaders pitch to Māori landowners - let us pay to plant trees and we will share the carbon credit profits

2018-08-16 nzherald.co.nz
A carbon-trading business seeking to unlock millions of dollars from communal Māori land is launching today in a scheme which will provide the Government's Billion Trees plan a massive boost.
ZNZ MTSI ZNRGF ZEL

 
Freightways, Sky TV lead NZ shares gain

2018-07-31 nzherald.co.nz
New Zealand shares gained, led higher by Freightways and Sky Network Television as the market remains quiet ahead of earnings season.
CEN ZNRGF KMD COENF SKT ZNZ GNE SYKWF SKC CEN SKKTY FGHRY KMD GEL KTHDY EBOSY FLT ZEL EBO COENY KWIPF EBOSF EVO GNE GTK EBO

1
NZ shares up, Pushpay rebounds from selling while Synlait, Sky TV gain

2018-07-27 nzherald.co.nz - 1
The S&P/NZX50 Index rose 63.68 points, or 0.7 per cent, to 8,996.16. Within the index, 25 stocks rose, 17 fell and eight were unchanged. Turnover was $87.5 million.
SKT ZNZ SYKWF THL ZNRGF SKKTY ZEL FTRRF SML

1
Revealed: Entrepreneur of the Year finalists

2018-07-26 nzherald.co.nz - 1
Twenty-two businesspeople from 17 businesses and industries are vying for the 2018 EY Entrepreneur of the Year.
ZNZ AIA AIA ZNRGF 3905 ACKDF ZEL AUKNY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...